Jennifer Baker, MD
- Surgical Oncology|
- Breast Surgery
About
Dr. Jennifer Baker is a breast surgeon and Associate Professor of Surgery at UCLA. She has a very busy clinical practice exclusively treating patients with breast cancer and/or at high risk for breast cancer. Dr Baker believes in intentional and personalized care for each patient; offering the most advanced surgical techniques tailored to an individual patient’s disease, preferences, and goals. She has extensive experience in nipple sparing mastectomy including with resensation techniques, oncoplastic lumpectomy, aesthetic flat closures, and targeted axillary surgery. She is deeply invested in ensuring superior patient oncologic and aesthetic outcomes and advancing breast cancer care.
Dr. Baker has been recognized for clinical excellence earning Super Doctors Rising Stars 2019-2024, LAs Top Docs 2020-2023, Fabletics Southern California Breast Cancer Heros 2024. In addition to her clinical work, she publishes regularly in many high impact surgical journals, serves on committees for the American Society of Breast Surgeons and Society of Surgical Oncology. She is also a member and Fellow of the American College of Surgeons. She is dedicated to teaching the next generation of surgeons and serves as the Associate Program Director for the breast surgical oncology fellowship at UCLA.
Dr. Baker is from West Des Moines, Iowa. She graduated with top honors, Alpha Omega Alpha from University of Iowa Carver College of Medicine, completed a general surgery residency at University of California, San Diego and a breast surgical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York
Languages
Education
Fellowship
Residency
Internship
Degree
Recognitions
- Top Doctors, Los Angeles Magazine, 2020-2023
- Super Doctors® Southern California Rising Stars 2020-2024
- Top Doctors, Pasadena Magazine, 2021-2023
- See More
Locations
Hospital Affiliations
Ronald Reagan UCLA Medical Center
UCLA Santa Monica Medical Center
Medical Services
Areas of Focus
Videos
Research
Interests
- Technique and outcomes associated with resensation procedures after nipple sparing mastectomy
- Aesthetic Flat Closure
- Breast Cancer in Young Women
- Epigenetic and gene pathways in breast cancer
- De-escalation of axillary surgery
Publications
-
Toesca A, Snagalli C, Maisonneuve P, Massari G, Girardi A, Baker JL, Lissigini G, Invento A, Farante G, Corso G, Rietjens M, Peradze N, Gottardi A, Magnoni F, Bottiglieri L, Laxxeroni M, Montagna E, Orecchia R, Galimberti V, Intra M, Sacchini V, Veronesi P. Robotic nipple-sparing mastectomy versus conventional open technique for breast cancer: an open-label, phase 3, single centre, randomized, controlled trial. Ann Surg. June 2021
-
Baker JL, Dizon D, Strega E, Thompson CK, Lee MK, Attai DJ. "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey. Ann Surg Oncol 2021 Jan 3. PMID 33393205
-
Baker JL, Hegde J, Thompson CK, Lee MK, DiNome ML. Locoregional Management of Inflammatory Breast Cancer. Current Breast Cancer Reports 12:326-335 (2020).
-
Angarita S, Ye L, Runger D, Hadaya J, Baker JL, Dawson N, Thompson CK, Lee MK, Attai DJ, DiNome ML. Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery. Ann Surg Oncology. Online first Oct 22, 2020. PMID 33084993
- Toesca A, Invento A, Massari G, Baker JL, et al. Update on the Feasibility and Progress on Robotic Breast Surgery. Ann Surg Oncol. 2019. 10.1245/s10434-019-07590-7
- Baker JL, Muhsen S, Zabor E, Stempel M, Gemignani M. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed? Ann Surg Oncol. 2019; 26:336-342
- Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015; 22 Suppl 3: 559-65. PMID 26275779
- Baker JL, Schwab RB, Wallace AM, Madlensky L. Breast Cancer in a RAD51D Mutation Carrier: Case Report and Review of the Literature. Clinical Breast Cancer. 2015; 15 (1):71-5. PMID 25445424
- Baker JL, Minya P, Messer K, Tokin CA, Hoh CK, Vera DR, Wallace AM. Comparison of [99mTc]Tilmanocept and Filtered-[99mTc]sulfur colloid for identification of SLNs in Breast Cancer Patients. Ann Surg Oncol. 2015; 22(1):40-5. PMID 25069859
- Weiss A, Tran V, Baker J, Farnaz H, Wallace AM, Chang D, Ojeda-Fournier H, Blair SL. Increased Likelihood of Mastectomy in Human Epidermal Growth Factor Receptor 2-positive Ductal Carcinoma In Situ. Am Surg. 2014 Oct; 80(10):936-9. PMID 25264633
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- L.A. Care
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.
Recognitions
- Top Doctors, Los Angeles Magazine, 2020-2023
- Super Doctors® Southern California Rising Stars 2020-2024
- Top Doctors, Pasadena Magazine, 2021-2023
- Dr. Tapan K Chaudhuri Award: Best Paper Breast Cancer Research, Society of Nuclear Medicine and Molecular Imaging Annual Meeting, 2013
- Graduated Alpha Omega Alpha from University of Iowa Medical School